Dr David Lovell
On this page
Skip the menu of subheadings on this page.
Image of Dr David Lovell in front of a yellow background wearing a blue shirt.
Bio
David Lovell is Emeritus Reader in Medical Statistics at St George’s Medical School, University of London. He was Chair of the UK Government’s Advisory Committees on Mutagenicity of Chemicals in Food, Consumer Products and the Environment (COM). He was a member of the Committee on Carcinogenicity (COC) both memberships expired in 2021.
He is a member of the Board of the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs).
Dr. Lovell's appointment as a member of the COT expires on 31st March 2025.
Personal Interest
|
Category of Interest |
Organisation / Body and Nature of Interest (period) |
|---|---|
| Retired |
Emiritus Reader in Medical Statistics, St Georges Medical School, University of London |
| Shareholder |
National Grid AstraZeneca (spouse shareholder) National Grid plc (spouse shareholder) |
| Membership |
HESI GTTC Biometrics Society British Toxicology Society Genetics Society Royal Society of Biology Laboratory Animal Science Association Royal Statistical Society Statisticians in the Pharmaceutical Industry United Kingdom Environment Mutagen Society (UKEMS) UK National Centre of Replacement, Refinement and Reduction of Animals in Research (NC3Rs) - Expired end 2022. MRC EMINENT Scientific Review Board UK Health Security Agency (UKHSA) Committee on Mutagenicity of Chemicals in Food, Consumer Products and the Environment & Committee on Carcinogenicity (COM & COC Expired 2021) Also private member of: British Trust of Ornithologists (BTO) English Heritage Liberty Campaign of the Protection of Rural England (CPRE) Kew Gardens Sandwich Bay Bird Observatory Trust (SBBOT) Chelsea Physic Garden National Trust |
| Pension |
I receive a pension from the Pfizer Pension Scheme related to when I worked for Pfizer from approx 1999-2004. I receive a USS pension from my past employment with the MRC and two Universities. |